A multiyear clinical trial comparing medication and mental health counseling in the treatment of post-traumatic stress disorder shows that
Day: October 19, 2018
Talzenna for treating metastatic breast cancer
Food and Drug Administration approved talazoparib (Talzenna, Pfizer Inc.), a poly (ADP-ribose) polymerase (PARP) inhibitor, for patients with deleterious or
Yutiq for treating chronic non-infectious posterior Segment Uveitis
U. S. Food and Drug Administration (FDA) has approved Yutiq™ (fluocinolone acetonide intravitreal implant) for the treatment of chronic non-infectious
The neurobiology of social aggression
Duke-NUS researchers have discovered that a growth factor protein, called brain-derived neurotrophic factor (BDNF), and its receptor, tropomyosin receptor kinase
Securing access to optimal cancer care through innovation, integration and sustainability
Securing access to optimal cancer care for all patients can only be achieved through integrated, sustainable translation of today’s scientific
Src regulates mTOR, a major player in cancer growth
A team of researchers at Baylor College of Medicine and Texas Children’s Hospital has revealed a connection between mTORC1 and
Scientists find brain signal that might help us judge the holiday buffet
At holiday buffets and potlucks, people make quick calculations about which dishes to try and how much to take of
Why some cancers affect only young women
Among several forms of pancreatic cancer, one of them affects specifically women, often young. How is this possible, even though
Huge variations between countries in time for reimbursement decisions on new cancer drugs
Some European countries take more than twice as long as others to reach health technology assessment (HTA) decisions to reimburse
Marijuana use might lead to higher risk of stroke, World Stroke Congress to be told
11th World Stroke Congress brings together leading international stroke experts and an unparalleled scientific program covering epidemiology, prevention, acute care,
